Novel synthetic drugs in migraine / Paolo Martelletti, Lars Edvinsson, editors.

Unlimited

Authorized users

Can lend chapters, not whole ebooks

Novel synthetic drugs in migraine / Paolo Martelletti, Lars Edvinsson, editors.

9783030953348 (electronic bk.)
3030953343 (electronic bk.)
9783030953331
3030953335

Cham : Springer, [2022]

©2022

English

1 online resource (ix, 109 pages : illustrations).

10.1007/978-3-030-95334-8 doi

RC392 .N68 2022eb

616.8/4912061

Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant). These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development.

Access limited to authorized users.

text file PDF

Online resource; title from PDF title page (SpringerLink, viewed May 5, 2022).

Headache (Springer (Firm))

Print version: 9783030953331

Online Resources > Ebooks
All Resources